Mutational spectrum and genotype-phenotype correlation in Mexican patients with infantile-onset and late-onset Pompe disease

被引:0
|
作者
Martinez-Montoya, Valentina [1 ,2 ]
Sanchez-Sanchez, Luz Maria [3 ]
Sandoval-Pacheco, Roberto [4 ]
Castro, Diana Monica Anaya [5 ]
Arellano-Valdez, Carmen Araceli [6 ]
Avila-Rejon, Carmen Amor [7 ]
Aguilar-Juarez, Pedro Alejandro [8 ]
Espino-Pluma, Martin [9 ]
Gonzalez-Santillanes, Cruz Antonio [10 ]
Martinez-Segovia, Rosa Isela [11 ]
Olmos-Morfin, Dorian [12 ]
la Torre, Ofelia Padilla-De [13 ]
Solis-Sanchez, Ishar [14 ]
Espinosa, Monica Vazquez-Del Mercado [15 ]
Villarroel-Cortes, Camilo Ernesto [16 ]
Velarde-Felix, Jesus Salvador [17 ]
Lopez-Valdez, Jaime [18 ]
Olaiz-Urbina, Julio [19 ]
Ricardez-Marcial, Edgar [20 ]
Vergara-Sanchez, Imelda [21 ]
Radillo-Diaz, Pablo [22 ]
Kazakova, Ekaterina [22 ]
De la Fuente-Cortez, Beatriz [23 ]
del Carmen Marquez-Quiroz, Luz [24 ,25 ]
Torres-Octavo, Benjamin [26 ]
Diaz-Martinez, Rubicel [27 ]
机构
[1] Inst Oftalmol Conde ABC Santa Fe, Prolongacion Vasco de Quiroga 4001,Torre A,4to pis, Mexico City 0537, Mexico
[2] Inst Med Vis, Genet Serv, Mexico City, Mexico
[3] Inst Mexicano Seguro Social IMSS, Hosp Especial UMAE 25, Pediat Serv, Monterrey, Nuevo Leon, Mexico
[4] Hosp Cent Mil Secretaria Def Nacl, Pediat Emergency Serv, Mexico City, Mexico
[5] Hosp Gen Dr Ernesto Ramos Bours, Neurol Serv, Secretaria Salud Publ, Hermosillo, Sonora, Mexico
[6] IMSS, Ctr Med Nacl Occidente, Pediat Internal Med & Rheumatol Serv, High Specialty Med Unit,Hosp Pediat, Guadalajara, Jalisco, Mexico
[7] Hosp Alta Especial Veracruz, Genet Dept, Serv Salud Veracruz, Xalapa, Veracruz, Mexico
[8] Ctr Med Nacl 20 Noviembre, Neurol Serv, Inst Segur & Serv Sociales Trabajadores Estado ISS, Mexico City, Mexico
[9] IMSS, Internal Med Serv, Clin Enfermedades Lisosomales, Hosp Gen Zona 1,Tlaxcala Xicohtencatl, Tlaxcala, Mexico
[10] IMSS, Hosp Gen Reg 1, Rehabil Serv, Culiacan, Sinaloa, Mexico
[11] Inst Mexicano Seguro Social IMSS, Hosp Especial UMAE 25, Internal Med Serv, Monterrey, Nuevo Leon, Mexico
[12] Ctr RehabilInfantil Teleton, Morelia, Michoacan, Mexico
[13] IMSS, Ctr Med Nacl Occidente, Neurol Serv, Guadalajara, Jalisco, Mexico
[14] Hosp Espanol Veracruz, Ctr Neurol, Clin Enfermedades Neuromusculares, Veracruz, Veracruz, Mexico
[15] Hosp Civil Dr Juan I Menchaca, Rheumatol Serv, Hosp Civil Dr, Guadalajara, Jalisco, Mexico
[16] Inst Nacl Pediat, Genet Serv, Mexico City, Mexico
[17] Univ Autonoma Sinaloa, Culiacan, Sinaloa, Mexico
[18] Centenario Hosp Miguel Hidalgo, Genet Serv, Secretaria Salud, Aguascalientes, Aguascalientes, Mexico
[19] IMSS, Pediat Serv, Hosp Gen Zona 1, La Paz, Baja California, Mexico
[20] IMSS, Ctr Med Nacl Raza, Genet Serv, Mexico City, Mexico
[21] IMSS, Pediat Neurol Serv, Unidad Med Alta Especial, Merida, Yucatan, Mexico
[22] Sanofi Genzyme, Med Dept Rare Dis, Mexico City, Mexico
[23] Univ Autonoma Nuevo Leon, Hosp Univ, Genet Serv, Monterrey, Nuevo Leon, Mexico
[24] Genos Med, Mexico City, Mexico
[25] Univ Nacl Autonoma Mexico, Mexico City, Mexico
[26] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Fibra Nerviosa Delgada, Mexico City, Mexico
[27] Hosp Reg Alta Especial Nino, Genet Serv, Secretaria Salud, Villahermosa, Tabasco, Mexico
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 07期
关键词
acid alpha-glucosidase; GAA gene; metabolic myopathy; phenotype-genotype correlation; Pompe disease; pseudodeficiency allele; rare disease; LYSOSOMAL STORAGE DISORDERS; GAA GENE; SCREENING-PROGRAM; GUIDELINES; VARIANTS;
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pompe Disease (PD) is a metabolic myopathy caused by variants in the GAA gene, resulting in deficient enzymatic activity. We aimed to characterize the clinical features and related genetic variants in a series of Mexican patients. Methods: We performed a retrospective study of clinical records of patients diagnosed with LOPD, IOPD or pseudodeficiency. Results: Twenty-nine patients were included in the study, comprising these three forms. Overall, age of symptom onset was 0.1 to 43 years old. The most frequent variant identified was c.-32-13T>G, which was detected in 14 alleles. Among the 23 different variants identified in the GAA gene, 14 were classified as pathogenic, 5 were likely pathogenic, and 1 was a variant of uncertain significance. Two variants were inherited in cis arrangement and 2 were pseudodeficiency-related benign alleles. We identified two novel variants (c.1615 G>A and c.1076-20_1076-4delAAGTCGGCGTTGGCCTG). Conclusion: To the best of our knowledge, this series represent the largest phenotypic and genotypic characterization of patients with PD in Mexico. Patients within our series exhibited a combination of LOPD and IOPD associated variants, which may be related to genetic diversity within Mexican population. Further population-wide studies are required to better characterize the incidence of this disease in Mexican population.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants
    Mei-Yan Chan
    Julaina Abdul Jalil
    Yusnita Yakob
    Siti Aishah Abdul Wahab
    Ernie Zuraida Ali
    Mohd Khairul Nizam Mohd Khalid
    Huey-Yin Leong
    Hui-Bein Chew
    Jeya Bawani Sivabalakrishnan
    Lock-Hock Ngu
    Orphanet Journal of Rare Diseases, 18
  • [22] Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel GAA variants
    Chan, Mei-Yan
    Jalil, Julaina Abdul
    Yakob, Yusnita
    Wahab, Siti Aishah Abdul
    Ali, Ernie Zuraida
    Khalid, Mohd Khairul Nizam Mohd
    Leong, Huey-Yin
    Chew, Hui-Bein
    Sivabalakrishnan, Jeya Bawani
    Ngu, Lock-Hock
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [23] Infantile-onset pompe disease: a tale of two cases
    Tolani, Drishti
    Bansal, Neha
    Sehgal, Swati
    CARDIOLOGY IN THE YOUNG, 2020, 30 (02) : 275 - 277
  • [24] Clinical guidelines for late-onset Pompe disease
    Barba-Romero, Miguel A.
    Barrot, Emilia
    Bautista-Lorite, Juan
    Gutierrez-Rivas, Eduardo
    Illa, Isabel
    Jimenez, Luis M.
    Ley-Martos, Myriam
    Lopez de Munain, Adolfo
    Pardo, Julio
    Pascual-Pascual, Samuel I.
    Perez-Lopez, Jordi
    Solera, Jesus
    Vilchez-Padilla, Juan J.
    REVISTA DE NEUROLOGIA, 2012, 54 (08) : 497 - 507
  • [25] Diagnosis and Management of Late-Onset Pompe Disease
    Hahn, Philipp
    Siefen, Rainer-Georg
    Benz, Korbinian
    Jackowski, Jochen
    Koehler, Cornelia
    Luecke, Thomas
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2024, 92 (01/02) : 33 - 40
  • [26] Is the brain involved in patients with late-onset Pompe disease?
    van den Dorpel, Jan J. A.
    van der Vlugt, Willemijn M. C.
    Dremmen, Marjolein H. G.
    Muetzel, Ryan
    van den Berg, Esther
    Hest, Roos
    de Kriek, Joni
    Brusse, Esther
    van Doorn, Pieter A.
    van der Ploeg, Ans T.
    van den Hout, Johanna M. P.
    van der Beek, Nadine A. M. E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2022, 45 (03) : 493 - 501
  • [27] A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease
    Wang, Zhaohui
    Okamoto, Patricia
    Keutzer, Joan
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : 92 - 100
  • [28] The emerging phenotype of late-onset Pompe disease: A systematic literature review
    Chan, Justin
    Desai, Ankit K.
    Kazi, Zoheb B.
    Corey, Kaitlyn
    Austin, Stephanie
    -Webb, Lisa D. Hobson
    Case, Laura E.
    Jones, Harrison N.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (03) : 163 - 172
  • [30] Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD)
    Mormina, Enricomaria
    Musumeci, Olimpia
    Tessitore, Agostino
    Ciranni, Anna
    Tavilla, Graziana
    Pitrone, Antonio
    Vinci, Sergio Lucio
    Caragliano, Antonio Armando
    Longo, Marcello
    Granata, Francesca
    Toscano, Antonio
    NEUROLOGICAL SCIENCES, 2021, 42 (06) : 2411 - 2419